Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MM01
- Development stage
- Preclinical
- Lead developer
- Artivila Therapeutics
- Modality
- Small Molecules
- Administration
- Intravenous
01
Overview
MM01 is an investigational small molecule therapeutic being developed by Artivila Therapeutics for the treatment of Systemic Lupus Erythematosus (SLE). As of early 2024, Artivila Therapeutics has not publicly disclosed the specific molecular target or the precise mechanism of action for this candidate. The drug is part of a broader pipeline of small molecule and antibody therapies focused on autoimmune diseases, oncology, and neurodegeneration. According to company pipeline information, the asset is currently in active development.
- Other names
- apoptosis-associated speck-like protein containing a caspase recruitment domain inhibitorASC inhibitorapoptosis-associated speck-like protein containing a caspase recruitment domain inhibitor MM01
02
Targets
PYCARD (Apoptosis-associated speck-like protein containing a CARD)
Beyond the preview
Go deeper on MM01.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MM01.